Liver Carcinoma — Trials

Liver Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,367 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 783
Recruiting: 463
Ph III recruiting: 41
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (386)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05620706	Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma	recruiting	N/A	20	Shenzhen University General HospitalOTHER	1	Nov 22, 2022	clinicaltrials
NCT04078230	Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma	recruiting	N/A	168	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	2	Nov 9, 2022	clinicaltrials